Identification of Benzimidazole Diamides as Selective Inhibitors of the Nucleotide-Binding Oligomerization Domain 2 (NOD2) Signaling Pathway

• David J. Rickard ,

  * E-mail: David.J.Rickard@gsk.com

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Clark A. Sehon,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Viera Kasparcova,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Lorena A. Kallal,

  Affiliation Biological Reagents and Assay Development, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Xin Zeng,

  Affiliation Screening and Compound Profiling, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Monica N. Montoute,

  Affiliation Screening and Compound Profiling, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Tushar Chordia,

  Affiliation Biological Reagents and Assay Development, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Derek D. Poore,

  Affiliation Biological Reagents and Assay Development, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Hu Li,

  Affiliation Biological Reagents and Assay Development, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Zining Wu,

  Affiliation Screening and Compound Profiling, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Patrick M. Eidam,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Pamela A. Haile,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Jong Yu,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• John G. Emery,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Robert W. Marquis,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Peter J. Gough,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
•  [ ... ],
• John Bertin

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• [ view all ]
• [ view less ]